SCHEMBL918555

SCHEMBL918555

CC(SC(=S)SCCC(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BHMT Q93088 1/20 0.33
FOLH1 Q04609 3/20 0.33
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
GABRB2 P47870 2/20 0.32
GABRA4 P48169 2/20 0.32
GABRE P78334 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31159619 0.82 CYP1A2 (0.44) CYP1A2TSHRHSD17B10LMNAKMT2A
SCHEMBL31550462 0.81 TSHR (0.41) CYP1A2TSHRHSD17B10LMNAKMT2A
SCHEMBL28512587 0.81 CYP2D6 (0.41) CYP1A2HSD17B10KMT2AHDAC3HDAC4
SCHEMBL180793 0.80 EPHX1 (0.36) HSD17B10LMNAALDH1A1
SCHEMBL12548837 0.79 HDAC3 (0.40) HSD17B10HDAC3HDAC4HDAC1HDAC7
SCHEMBL31539134 0.77 EPHX1 (0.45) TSHRHSD17B10KMT2ATDP1HDAC11
SCHEMBL181033 0.77 EPHX1 (0.45) TSHRHSD17B10KMT2ATDP1HDAC11
SCHEMBL4455772 0.77 CYP1A2 (0.65) CYP1A2TSHRHSD17B10LMNAKMT2A
SCHEMBL1549986 0.77 ALDH1A1 (0.40) HSD17B10LMNAALDH1A1
SCHEMBL24049300 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119424774-B Alloy cardiovascular stent and surface coating process thereof 上海瑞邦生物材料有限公司 2025-06-03 CN claimed
CN-119823335-A Block type dispersing agent, preparation method, electrode slurry, electrode plate and battery 上海三瑞高分子材料股份有限公司 2025-04-15 CN claimed
EP-4514595-A1 METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
CN-119424774-A Alloy cardiovascular stent and surface coating process thereof 上海瑞邦生物材料有限公司 2025-02-14 CN claimed
CN-118496449-A Block dispersant, preparation method and carbon black slurry 上海三瑞高分子材料股份有限公司 2024-08-16 CN claimed
US-11834383-B2 Energetic feedstock for additive manufacturing LYNNTECH, INC. (US) 2023-12-05 US claimed
WO-2023209570-A1 METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES ALCON INC. (CH) 2023-11-02 WO claimed
EP-4240578-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES Alcon Inc. (CH) 2023-09-13 EP claimed
WO-2022229952-A1 POLYMERS AND USES THEREOF IN ENERGY STORING DEVICES 3DBATTERIES LTD. (IL) 2022-11-03 WO claimed
WO-2022097048-A1 METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES ALCON INC. (CH) 2022-05-12 WO claimed
US-20210276931-A1 Energetic Feedstock for Additive Manufacturing LYNNTECH, INC. 2021-09-09 US claimed
EP-3334766-A1 THIOCARBONYLTHIO-FREE RAFT POLYMERS AND THE PROCESS OF MAKING THE SAME Henkel IP & Holding GmbH (DE) 2018-06-20 EP claimed
US-20180155463-A1 THIOCARBONYLTHIO-FREE RAFT POLYMERS AND THE PROCESS OF MAKING THE SAME Henkel IP & Holding GmbH (DE) 2018-06-07 US claimed
US-9624317-B2 Amphiphilic macromolecular emulsifier with switchable surface activity and use thereof in preparation of polymer latex ZHEJIANG UNIVERSITY (CN) 2017-04-18 US claimed
WO-2017027557-A1 THIOCARBONYLTHIO-FREE RAFT POLYMERS AND THE PROCESS OF MAKING THE SAME Henkel IP & Holding GmbH (DE) 2017-02-16 WO claimed
US-20140316049-A1 AMPHIPHILIC MACROMOLECULAR EMULSIFIER WITH SWITCHABLE SURFACE ACTIVITY AND USE THEREOF IN PREPARATION OF POLYMER LATEX ZHEJIANG UNIVERSITY (CN) 2014-10-23 US claimed
US-20260131506-A1 METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES ALCON INC (CH) 2026-05-14 US disclosed
US-20260109953-A1 XENO-FREE PEHA POLYMERS FOR 3D PRINTING AND METHODS OF MAKING AND USING THE SAME UNIV INDIANA TRUSTEES (US) 2026-04-23 US disclosed
WO-2009012202-A1 MINERAL DISPERSANTS AND METHODS FOR PREPARING MINERAL SLURRIES USING THE SAME KEMIRA OYJ (FI) 2009-01-22 WO disclosed
US-20090014695-A1 Polyelectrolytes as improved grinding aids and improved dispersants for mineral grinding and slurry viscosity stability using a polyacrylic acid from RAFT (reversible addition-fragmentation chain transfer polymerization) having thio-containing end groups; polydispersity KEMIRA OYJ (FI) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109953-A1 XENO-FREE PEHA POLYMERS FOR 3D PRINTING AND METHODS OF MAKING AND USING THE SAME PLOD3, PBK, PLOD1 CYP1A2 2045/4885TSHR 1232/4885HSD17B10 2512/4885
US-20260131506-A1 METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES CRYZ, CRYAB, CRYAA CYP1A2 1256/4885TSHR 907/4885HSD17B10 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.